Although the COVID pandemic led to a better understanding of the coronaviruses, viruses, and vaccines, a backlash emerged to ...
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...
Pandemic prevention system wins $100 million award to expand surveillance in Nigeria and other parts of Africa.
Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...
In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann ...
Critical illness poses a significant global health challenge, disproportionately affecting low- and middle-income countries ...
It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.